drugset / Trial / NCT03139565

High Dose vs. Standard Influenza Vaccine in Adult SOT

NCT03139565 ↗

Phase 3 Completed 172 enrolled University Health Network, Toronto
RandomizedParallel-groupTriple-blindPrevention

Summary

The study will test whether a high dose influenza vaccination results in improved immunogenicity in adult SOT recipients as compared to standard vaccine. This will be a single center prospective observer-blind randomized controlled trial conducted at the Toronto General Hospital Multi-Organ Transplant Unit, University Health Network, Toronto, Ontario, Canada.

Timeline

Start
2016-10
Primary completion
2017-06
Completion
2020-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluzone High-dose Influenza Vaccine Vaccine 60 ug Intramuscular
Comparator Standard 2016-2017 Flu vaccine Vaccine 15 ug Intramuscular
Comparator Standard 2016-2017 Flu vaccine Vaccine 0.5 ml Intramuscular